Monday, October 26, 2026 · Daily editionET --:--:--

Stopped early

Robotic Seed Implantation for Prostate Cancer Brachytherapy

NCT01341288 · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University · Updated 2 May 2025

What is being tested
EUCLIDIAN Robot
For
Prostate Cancer
Kind of study
Tests a treatment or device on volunteers. Phase 1.
Who can join
Ages 40 years and older. About 2 people. The full rules are on the registry page.
Where
United States
When
Starts or started 29 July 2008, ends 27 Feb 2015. Registered 25 April 2011.
Results
None posted yet.

In the researchers' words

A robotic brachytherapy device will be used to assist physicians in performing seed implantation to the prostate. EUCLIDIAN is the first robotic system designed to allow automatic placement of radioactive seeds by robot and thus reduce operator dependence. The clinical study is designed to evaluate the dosimetric quality, accuracy and patient self-reported quality of life scores after robotic brachytherapy.
ClinicalTrials.gov, NCT01341288

Sites

  • Thomas Jefferson UniversityPhiladelphia, Pennsylvania, United States